Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials

被引：0
|
作者：
Ibrahim Elmakaty
Ruba Abdo
Ahmed Elsabagh
Abdelrahman Elsayed
Mohammed Imad Malki
机构：
[1] QU Health,College of Medicine
[2] Qatar University,Pathology Unit, Department of Basic Medical Sciences, College of Medicine
[3] QU Health,undefined
[4] Qatar University,undefined
来源：
Cancer Cell International | / 23卷
关键词：
PD-1/PD-L1 inhibitors; Immune checkpoint inhibitors; Overall survival; Progression-free survival; Pathological complete response; Adverse events; Efficacy; Safety; Systematic review; Network meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF PD-1/PD-L1 INHIBITORS USED IN THE TREATMENT OF PATIENTS WITH ADVANCED AND METASTATIC MELANOMA - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Verma, J.
    Verma, D.
    Maria, A.
    VALUE IN HEALTH, 2020, 23 : S50 - S50
  • [32] Assessment of the Clinical Trials Safety Profile of PD-1/PD-L1 Inhibitors Among Patients With Cancer: An Updated Systematic Review and Meta-Analysis
    Tian, Yuan
    Huang, Alan
    Yang, Yue
    Dang, Qi
    Wen, Qing
    Wang, Linlin
    Sun, Yuping
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors in the treatment of hepatocellular carcinoma: A meta-analysis and systematic review
    Zhang, Baoyan
    Su, Linfeng
    Lin, Yonghua
    ONCOLOGY LETTERS, 2024, 28 (01)
  • [34] The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis
    Wang, Bi-Cheng
    Cao, Ru-Bo
    Fu, Chen
    Chen, Wang-Bing
    Li, Pin-Dong
    Lin, Guo-He
    Qian, Xiao-Jun
    Li, Yun-Tian
    Liu, Quentin
    ORAL ONCOLOGY, 2020, 104
  • [35] Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis
    Wang, Xiaohui
    Bao, Zhengqiang
    Zhang, Xiaoju
    Li, Fei
    Lai, Tianwen
    Cao, Chao
    Chen, Zhihua
    Li, Wen
    Shen, Huahao
    Ying, Songmin
    ONCOTARGET, 2017, 8 (35) : 59901 - 59914
  • [36] Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials
    Luo, Wenxin
    Wang, Zhoufeng
    Tian, Panwen
    Li, Weimin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (10) : 1851 - 1859
  • [37] Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials
    Wenxin Luo
    Zhoufeng Wang
    Panwen Tian
    Weimin Li
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1851 - 1859
  • [38] Efficacy of PD-1 and PD-L1 inhibitors in older adults: A meta-analysis
    Elias, Rawad
    Giobbie-Hurder, Anita
    Rahma, Osama E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Efficacy of PD-1/PD-L1 Inhibitors versus Chemotherapy in Lung Cancer with Brain Metastases: A Systematic Review and Meta-Analysis
    Yang, Xiaojun
    Zeng, Yihong
    Tan, Qinquan
    Huang, Zhihua
    Jia, Jun
    Jiang, Guanming
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [40] Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
    Elias, Rawad
    Giobbie-Hurder, Anita
    McCleary, Nadine Jackson
    Ott, Patrick
    Hodi, F. Stephen
    Rahma, Osama
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
12345